Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is bladder cancer?
The bladder is the hollow organ that stores urine. Bladder cancer begins in the cells lining its inner wall and frequently first appears as painless blood in the urine. The single most important question is whether the cancer is still on the surface lining (non-muscle-invasive) or has grown into the bladder's muscle wall (muscle-invasive), because that decides the entire treatment path. Smoking and certain workplace chemicals are the leading risk factors.
The main types
Doctors group bladder cancer by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Urothelial carcinoma | Over 90% of cases; starts in the urothelial cells that line the bladder and urinary tract. |
| Non-muscle-invasive (NMIBC) | Cancer limited to the surface lining. Often treated by removing it and placing medicine directly into the bladder; rarely life-threatening but tends to come back, so it needs monitoring. |
| Muscle-invasive (MIBC) | Cancer has grown into the bladder's muscle. More serious and treated more aggressively — with surgery or bladder-preserving chemoradiation. |
Staging, in plain terms
Staging uses T (how deep the tumor grows into the bladder wall), N (lymph nodes involved), and M (metastasis/distant spread). The key dividing line is whether the tumor has reached the muscle layer.
| TNM | What it generally means |
|---|---|
| Stage 0 | Cancer only on the inner surface lining (including flat 'carcinoma in situ'). Treated through the urethra, often with bladder medicine. |
| Stage I | Grown into the connective tissue under the lining but not the muscle. Still non-muscle-invasive. |
| Stage II | Grown into the bladder's muscle wall (muscle-invasive). Calls for more aggressive treatment. |
| Stage III | Spread through the bladder wall to nearby tissue or lymph nodes in the pelvis. |
| Stage IV | Spread to distant lymph nodes or organs. Treated with medicines, including immunotherapy, often controlling disease for a long time. |
The standard of care
Bladder Cancer is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Transurethral resection (TURBT) + bladder therapy
For surface tumors, the cancer is scraped away through the urethra, often followed by medicine (such as BCG) placed inside the bladder to stop it returning.
Bladder-preserving chemoradiation
For many muscle-invasive cancers, combining radiation with chemotherapy (trimodality therapy) can cure the cancer while keeping the bladder.
Surgery (cystectomy) & systemic medicine
Removing the bladder is a standard option for muscle-invasive disease; chemotherapy before surgery and immunotherapy improve outcomes.
How radiation treatment works
Radiation uses focused high-energy x-rays to damage cancer-cell DNA so the cells can no longer divide. Healthy cells repair this damage better than cancer cells, so fractionated treatment clears cancer while sparing normal tissue. Because the bladder changes size as it fills, image guidance checks its position at each session to keep the beam on target. Treatments are painless and brief; side effects can include temporary urinary urgency, loose stools, and fatigue that usually settle after treatment.
The main ways radiation is delivered for bladder cancer:
Trimodality therapy (TMT)
After a thorough TURBT, daily radiation is combined with radiation-sensitizing chemotherapy. For well-selected patients, cure rates approach surgery while preserving a working bladder.
Image-guided external-beam (IMRT/IGRT)
Shapes the dose to the bladder and pelvis and adjusts for the bladder filling differently each day, protecting the bowel and rectum.
Palliative radiation
Short courses of radiation can quickly stop bleeding or relieve symptoms when the goal is comfort rather than cure.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Bladder preservation matches surgery: Large analyses show trimodality chemoradiation offers survival comparable to bladder removal for suitable muscle-invasive cancers — while keeping the bladder.[1]
Pooled trimodality cohorts; RTOG trials
Adding immunotherapy to chemoradiation: Trials are testing whether immunotherapy alongside bladder-preserving radiation further improves cure rates, building on its proven benefit in advanced disease.[2]
Ongoing phase III bladder-preservation trials
Hypofractionated radiation is convenient and effective: A shorter, more intense radiation schedule was shown to be at least as good as the longer course for muscle-invasive bladder cancer.[3]
UK BC2001 / hypofractionation meta-analysis
Common questions
I saw blood in my urine — does that mean cancer? Not necessarily; infections and other causes are common. But painless blood in the urine should always be checked promptly, because it is the most frequent early sign of bladder cancer.
Can I keep my bladder? Often, yes. Surface tumors are treated through the urethra, and many muscle-invasive cancers can be cured with bladder-preserving chemoradiation instead of removing the bladder.
Why does bladder cancer keep coming back? Surface bladder cancers tend to recur, which is why regular follow-up looks inside the bladder over time. Catching a recurrence early keeps it easy to treat.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.